Women's Hormonal and Metabolic Wellbeing
Official title: A 12-Week Virtual, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effects of Daily Nouri Hormone Balance Probiotic on Metabolic, Inflammatory, and Symptom Outcomes in Women
Run by Daily Nouri · NCT07268404 · Data updated 2026-11-12
This 12-week test will see if taking Daily Nouri's Hormone Balance probiotic every day helps women with irregular menstrual cycles and hormone-related symptoms improve metabolic markers, inflammation, and daily symptoms.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 60 (estimated) |
| Sponsor | Daily Nouri Industry-sponsored |
| Locations | 1 site (San Francisco, California) |
| Status | Recruiting |
| Started | December 10, 2025 |
| Main results expected | October 2026 |
| Study ends | December 2026 |
| Registry record updated | August 25, 2026 |
| Trial ID | NCT07268404 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women with self-reported irregular menstrual cycles and one or more hormone-related concerns (such as skin issues, unwanted hair growth, hair thinning, or weight concerns) who are not currently using the excluded medications are the intended participants.
✕Probably not a fit
Individuals currently on hormonal therapies, metformin, GLP-1 receptor agonists, or anti-androgens, or those unwilling to stop supporting supplements for the washout or provide required blood samples, are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a 12-week, randomized, placebo-controlled trial in which participants take either a probiotic blend capsule or matching placebo daily. All study visits are conducted virtually, including symptom questionnaires and remote reporting, while blood samples are collected at baseline and follow-up to measure metabolic and inflammatory markers. Eligible participants report irregular menstrual cycles for at least six months and at least one hormone-related concern and must not be using hormonal therapies, metformin, GLP-1 agonists, or anti-androgens. Participants taking menstrual/hormonal supplements must stop them for a two-week washout before baseline and remain weight-stable during the study.
Why it matters
Potential benefit: If successful, the probiotic could provide a low-risk daily supplement option to reduce inflammation, improve metabolic measures, and relieve some hormone-related symptoms for some women.
How similar studies have gone: Some small trials have shown modest metabolic or inflammatory benefits from specific probiotic formulations, but evidence directly supporting probiotics for menstrual irregularity and related hormone symptoms remains limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Self-reported irregular menstrual cycles, defined as one or more of the following: * Cycle length typically \>35 days OR \<21 days * Fewer than 9 menstrual periods in the past year * Unpredictable cycle timing (varies by \>7 days month-to-month) * Irregular cycles present for ≥6 months * One or more of the following hormonal balance concerns: skin, unwanted hair growth, hair thinning, weight concerns) * Self-reported emotional symptoms that fluctuate with menstrual cycle, including: * Mood swings or irritability * Feelings of stress or tension * Low mood or feeling down * Difficulty with emotional regulation * Not currently using hormonal therapies, metformin, GLP-1 receptor agonists, or anti-androgens. * If taking supplements for menstrual/hormonal support: willing to discontinue for 2-week washout before baseline * Weight stable (+ 5 pounds) for the past 2 months, not planning to start a new diet, exercise program, or medications during study * Able to provide electronic informed consent. * Willing to complete online surveys and at-home DBS sample collection. * Negative home pregnancy test at baseline. * Access to a computer or smartphone and reliable internet connection.
Where it's running
-
Alethios, Inc.
San Francisco, California, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Bringing preventive cardiovascular care to Indigenous and remote communities
This project tests a mobile health unit to screen and provide culturally safe cardiovascular and metabolic care for Indigenous and remote communities in Canada.
-
Do Quercefit® or Ubiqsome™ help with aging and metabolic health in adults 50–75?
This study tests whether Quercefit® or Ubiqsome™ can improve aging markers, blood sugar, and heart health in sedentary adults aged 50–75 compared with a placebo.
-
Diet, Fat Quality, and How Your Body Responds to Exercise
This observation study tests whether your usual fat quality in diet and metabolic health relate to how you feel during and after exercise, plus your cognitive function and school-related engagement.
-
Agentic AI personalized dietary management
This study tests an AI-powered, personalized diet plan to see if it helps adults improve eating habits and metabolic health over 12 weeks.
-
Dance Exercise for Metabolic and Mental Health in Women
A 6-month program of supervised dance workouts will be tested to see if it improves metabolic health, mental health, and physical performance in premenopausal and postmenopausal inactive women in Greece.
-
Dairy versus plant-based yogurt effects on weight, muscle, bones, and gut bacteria
This study will test whether eating dairy yogurt instead of a plant-based yogurt (or no yogurt) helps postmenopausal women with overweight or obesity maintain muscle and bone health, control weight, and change gut bacteria.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.